STRO — Sutro Biopharma Share News
0.000.00%
Last trade - 00:00- $154.70m
- $229.42m
- $102.48m
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates
Sutro Biopharma Q2 revenue misses estimates, posts wider loss
Brief: Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million
Sutro Biopharma Inc expected to post a loss of $2.22 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals
Sutro Biopharma Q1 revenue beats analyst expectations
Brief: Sutro Biopharma Q1 Revenue USD 14.523 Million Vs. IBES Estimate USD 8.08 Million
Brief: Sutro Biopharma Enters Sales Agreement, May Offer & Sell Shares Of Common Stock Of Up To $100 Million - SEC Filing
Sutro Biopharma tops 2025 revenue estimates
NASDAQ RESUMED AT 09:30 AM
Brief: Sutro Biopharma Announces First Cohort Of Patients Dosed In Phase 1 Trial Of Stro-004
NASDAQ RESUMED AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Sutro Biopharma Announces 1-For-10 Reverse Stock Split